Literature DB >> 28082678

The Activating C-type Lectin-like Receptor NKp65 Signals through a Hemi-immunoreceptor Tyrosine-based Activation Motif (hemITAM) and Spleen Tyrosine Kinase (Syk).

Björn Bauer1, Tanja Wotapek1, Tobias Zöller1, Emilia Rutkowski1, Alexander Steinle2.   

Abstract

NKp65 is an activating human C-type lectin-like receptor (CTLR) triggering cellular cytotoxicity and cytokine secretion upon high-affinity interaction with the cognate CTLR keratinocyte-associated C-type lectin (KACL) selectively expressed by human keratinocytes. Previously, we demonstrated that NKp65-mediated cellular cytotoxicity depends on tyrosine 7, located in a cytoplasmic sequence motif of NKp65 resembling a hemi-immunoreceptor tyrosine-based activation motif (hemITAM). HemITAMs have been reported for a few activating myeloid-specific CTLRs, including Dectin-1 and CLEC-2, and consist of a single tyrosine signaling unit preceded by a triacidic motif. Upon receptor engagement, the hemITAM undergoes phosphotyrosinylation and specifically recruits spleen tyrosine kinase (Syk), initiating cellular activation. In this study, we addressed the functionality of the putative hemITAM of NKp65. We show that NKp65 forms homodimers and is phosphorylated at the hemITAM-embedded tyrosine 7 upon engagement by antibodies or KACL homodimers. HemITAM phosphotyrosinylation initiates a signaling pathway involving and depending on Syk, leading to cellular activation and natural killer (NK) cell degranulation. However, although NKp65 utilizes Syk for NK cell activation, a physical association of Syk with the NKp65 hemITAM could not be detected, unlike shown previously for the hemITAM of myeloid CTLR. Failure of NKp65 to recruit Syk is not due to an alteration of the triacidic motif, which rather affects the efficiency of hemITAM phosphotyrosinylation. In summary, NKp65 utilizes a hemITAM-like motif for cellular activation that requires Syk, although Syk appears not to be recruited to NKp65.
© 2017 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  NKp65; cell surface receptor; hemITAM; innate immunity; lectin; natural killer cells (NK cells); signal transduction; spleen tyrosine kinase (Syk)

Mesh:

Substances:

Year:  2017        PMID: 28082678      PMCID: PMC5336157          DOI: 10.1074/jbc.M116.759977

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  44 in total

Review 1.  Natural killer cell memory in infection, inflammation and cancer.

Authors:  Adelheid Cerwenka; Lewis L Lanier
Journal:  Nat Rev Immunol       Date:  2016-01-25       Impact factor: 53.106

2.  Natural killer cell signaling pathways.

Authors:  Eric Vivier; Jacques A Nunès; Frédéric Vély
Journal:  Science       Date:  2004-11-26       Impact factor: 47.728

3.  The novel Syk inhibitor R406 reveals mechanistic differences in the initiation of GPVI and CLEC-2 signaling in platelets.

Authors:  J C Spalton; J Mori; A Y Pollitt; C E Hughes; J A Eble; S P Watson
Journal:  J Thromb Haemost       Date:  2009-04-24       Impact factor: 5.824

4.  NKp80 defines and stimulates a reactive subset of CD8 T cells.

Authors:  Sabrina Kuttruff; Sven Koch; Alexandra Kelp; Graham Pawelec; Hans-Georg Rammensee; Alexander Steinle
Journal:  Blood       Date:  2008-10-15       Impact factor: 22.113

5.  Structure of NKp65 bound to its keratinocyte ligand reveals basis for genetically linked recognition in natural killer gene complex.

Authors:  Yili Li; Qian Wang; Sharon Chen; Patrick H Brown; Roy A Mariuzza
Journal:  Proc Natl Acad Sci U S A       Date:  2013-06-26       Impact factor: 11.205

6.  Attenuated natural killer (NK) cell activation through C-type lectin-like receptor NKp80 is due to an anomalous hemi-immunoreceptor tyrosine-based activation motif (HemITAM) with impaired Syk kinase recruitment capacity.

Authors:  Thomas Rückrich; Alexander Steinle
Journal:  J Biol Chem       Date:  2013-04-22       Impact factor: 5.157

7.  Genetically coupled receptor-ligand pair NKp80-AICL enables autonomous control of human NK cell responses.

Authors:  Sascha N Klimosch; Yvonne Bartel; Stefan Wiemann; Alexander Steinle
Journal:  Blood       Date:  2013-08-08       Impact factor: 22.113

8.  CLEC2A: a novel, alternatively spliced and skin-associated member of the NKC-encoded AICL-CD69-LLT1 family.

Authors:  Jessica Spreu; Eike C Kienle; Birgit Schrage; Alexander Steinle
Journal:  Immunogenetics       Date:  2007-11-29       Impact factor: 2.846

Review 9.  The kinetic-segregation model: TCR triggering and beyond.

Authors:  Simon J Davis; P Anton van der Merwe
Journal:  Nat Immunol       Date:  2006-08       Impact factor: 25.606

10.  Syk-dependent phosphorylation of CLEC-2: a novel mechanism of hem-immunoreceptor tyrosine-based activation motif signaling.

Authors:  Sonia Séverin; Alice Y Pollitt; Leyre Navarro-Nuñez; Craig A Nash; Diego Mourão-Sá; Johannes A Eble; Yotis A Senis; Steve P Watson
Journal:  J Biol Chem       Date:  2010-11-22       Impact factor: 5.157

View more
  2 in total

1.  A computational model for regulation of nanoscale glucan exposure in Candida albicans.

Authors:  Michael J Wester; Jia Lin; Aaron K Neumann
Journal:  PLoS One       Date:  2017-12-12       Impact factor: 3.240

Review 2.  Taking Lessons from CAR-T Cells and Going Beyond: Tailoring Design and Signaling for CAR-NK Cells in Cancer Therapy.

Authors:  Katharina Eva Ruppel; Stephan Fricke; Ulrike Köhl; Dominik Schmiedel
Journal:  Front Immunol       Date:  2022-03-18       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.